Dr. Reddy's Laboratories has launched Bupropion Hydrochloride Extended-Release Tablets, USP (SR), a therapeutically equivalent generic version of Zyban (Bupropion Hydrochloride) Extended-Release Tablets, approved by the US Food and Drug Administration (USFDA).
The Zyban brand and generic had US sales of approximately $5.4 million MAT for the most recent twelve months ending in June 2019 according to IQVIA Health. Dr. Reddy's Bupropion Hydrochloride Extended-Release Tablets, USP (SR) are available as 150 mg dosage strength in bottle count sizes of 60.
Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.
Got a minute? Help us shape our products!
Thank you for being a registered user on MoneyWorks4me (SEBI Registered: INA000013323) - with 2.75 lac+ registered users.
We are working on shaping our products to enable you confidently invest in stocks. Towards this we want to understand your needs and priorities better. It will only take a minute and would help us serve you better!
What more? You get special offer as token of appreciation of your valuable feedback once new version is launched. We assure you it will be a solution you will be happy to use!